CURRICULUM VITAE

INFORMAZIONI PERSONALI

Nome Andrea Pace

Data di nascita 2/8/1955

Qualifica Medico Chirurgo, Neurologo

Amministrazione IFO

Incarico attuale Responsabile UOSD Neuroncologia

Numero telefonico dell’ufficio 0652666067

Fax dell’ufficio 0652665068

E-mail istituzionale pace@ifo.it

TITOLI DI STUDIO E

PROFESSIONALI ED ESPERIENZE

LAVORATIVE

Titolo di studio Laurea in Medicina e Chirurgia 26/7/1983 (Università la Sapienza

di Roma) con 110/110 e lode

Altri titoli di studio e professionali Specializzazione in Neurologia 24/7/1987 (Università la

Sapienza di Roma) con 70/70 e lode

Esperienze professionali ( incarichi

ricoperti)

Dal 1/5/2011 Istituto Nazionale Tumori Regina Elena

Responsabile SSD Neuroncologia

Dal 5/10/2009 Istituto Nazionale Tumori Regina Elena

Responsabile ff SSD Neurologia

Dal Maggio 2003 Responsabile della SSO di ambulatorio di

neuro-oncologia e assistenza continuativa domiciliare neuro-

oncologica

2001 ad oggi Corso di Laurea in Scienze infermieristiche

Università di Roma La Sapienza, Professore a contratto

1993 ad ottobre 2009 Istituto Nazionale Tumori Regina Elena –

Neurologo

1988-1993 IRCCS S Lucia di Roma Assistente medico neurologo

Capacità linguistiche Inglese, ottima conoscenza scritta e parlata

Capacità nell’uso delle tecnologie

Altro ( partecipazione a convegni e

seminari, pubblicazioni,

collaborazioni a riviste, ecc. ed

ogni altra informazione che il

Membro del Direttivo dell’Associazione Italiana di Neuro-

Oncologia

Membro del gruppo di studio SIN (Società Italiana Neurologia) di

Neuro-Oncologia

dirigente ritiene di dover

pubblicare)

Membro del gruppo di studio SIN di Bioetica

Socio SIN,SNO,SICP,AINO,EANO.

Member of editorial board of Neuroncology Journal

Member of editorial board of Neuroncology Practice Journal

Pubblicazioni su riviste recensite:

1-Pace A, Grassa C, Cavalletti C, Figa' Talamanca L: Complications of

cerebral angiography. Statistical analysis of 1260 cases. Recenti Prog

Med 1984 Feb;75(2):132-41

2-Bernardi S, Buttinelli C, Grasso MG, Millefiorini E, Pace A,

Prencipe M, Fieschi C.: Evolution and severity markers in 233 MS

patients. Riv Neurol. 1987 May-Jun;57(3):197-200.

3-Fieschi C, Argentino C, Lenzi GL, Fantozzi L, Sacchetti ML, Pace

A, Rasura M, Bastianello S, Bozzao L, Zanette E, et al. Therapeutic

window for pharmacological treatment in acute focal cerebral

ischemia. Ann N Y Acad Sci. 1988;522:662-6

4-Buttinelli C, Pace A, Mauriello A, Sette G, Bonanno E, Zanette EM.

B-mode echography in carotid pathology: correlation with

morphology. Minerva Med. 1988 Aug;79(8):665-7

5-Giubilei F, Argentino C, Silvestrini M, Pace A, Rasura M, Di Piero

V, Intiso D, Bastianello S, Paris L, Lenzi GL, et al.Prognostic factors

in acute cerebral infarct. Minerva Med. 1988 Aug;79(8):637-40.

6-Pietrangeli A, Finocchiaro R, Pace A, Rinaldi M, Jandolo B. The

effect of brain radiotherapy on the P3 component of ERP's. J

Neurosurg Sci. 1990 Jul-Dec;34(3-4):327-8.

7-Jandolo B, Pietrangeli A, Pace A, Carapella CM, Finocchiaro R,

Morace E.Brain-stem auditory evoked potentials in supratentorial brain

tumors. Electromyogr Clin Neurophysiol. 1992 Jun;32(6):307-9.

8-Grasso MG, Pantano P, Ricci M, Intiso DF, Pace A, Padovani A,

Orzi F, Pozzilli C, Lenzi GL. Mesial temporal cortex hypoperfusion is

associated with depression in subcortical stroke. Stroke. 1994

May;25(5):980-5.

9-Pace A., Pietrangeli A., Bove L., Rosselli M., Lopez M., Jandolo

B.:Neurotoxicity of antitumoral IL-2 therapy: evoked cognitive

potentials and brain mapping. Ital J Neurol Sci 15: 341-346, 1994.

10-Jandolo B., Della Giulia M., Pace A., Pietrangeli A. et al:

Neurophysiological examination of end-plate function in patients with

lung cancer. Electromyogr clin neurophysiol 35: 247-250, 1995.

11-Pietrangeli A., Bove L., Innocenti P., Pace A.:Meningiti

carcinomatose: aspetti clinici e decorso in 5 pazienti trattati con

metotrexate endorachide. Riv. Neurobiologia, 41(5), 671-675,1995.

12-Pace A., Jandolo B: Taxoids neurotoxicity. Neurology 47, 615,

1996.

13-Pace A., Bove L., Nisticò C, et al : Vinorelbine neurotoxicity:

clinical and neurophysiological findings in 23 patients. Journal of

Neurology, Neurosurgery and Psychiatry 61,4: 409-411, 1996.

14-Jandolo B., Pietrangeli A., Pace A. et al: Electrophysiological

testing in patients operated with the nerve sparing technique for

bladder and prostate. J Exp Clin Cancer Res 15: 67-70, 1996.

15-Fuoco U, Scivoletto G, Pace A, Vona VU, Castellano V. Anaemia

and serum protein alteration in patients with pressure ulcers. Spinal

Cord. 1997 Jan;35(1):58-60.

16-Pace A., Bove L., Aloe A, et al: Paclitaxel neurotoxicity: clinical

and neurophysiological study of 23 patients. Ital J Neurol Sci, 18:73-

79, 1997

17-Pace A., Innocenti P., Bove L., et al: Epilessia come sintomo di

esordio e nel decorso della malattia in 143 pazienti affetti da neoplasia

cerebrale emisferica. Boll Lega It Epil, 99:269-270, 1997.

18-Pietrangeli A., Bove L., Innocenti P., Pace A. et al:

neurophysiological evaluation of sexual dysfunction in patients

operated for colorectal cancer. Clinical Autonomic Research 8,6:353-

356, 1998

19-Pace A., Bove L., Innocenti P. et al: Epilepsy and gliomas:

Incidence and treatment in 119 patients. J Exp Clin Cancer Res, 17,4:

479-482, 1998

20-Pace A. Assistenza domiciliare neuro-oncologica. Il progetto

Qualità della vita dell’Istituto Regina Elena. Notiziario dei Comitati

Gigi Ghirotti. 1999

21-C.Nistico’, C.Garufi, M.Milella, A.Vaccaro, AM D’Ottavio,

A.Fabi, A.Pace, L.Bove, F.Tropea, A.Marsella, F.Izzo, RM D’Attimo,

V.Ferraresi, S.De Marco, E.Terzoli: Weekly schedule of vinorelbine in

pretreated breast cancer patients. Breast Cancer Research and

Treatment 59: 223-229, 2000

22-S.De Santis. A.Pace, L.Bove, F.Cognetti, F.Properzi, M.Fiore,

V.Triaca, A.Savarese, MD Simone, B.Jandolo, L.Manzione, L.Aloe:

Patients Treated with Antitumor Drugs Dispalying Neurological

Deficits Are Characterized by a Low Circulating Level of Nerve

Growth Factor Clinical Cancer Research 6, 90-95, January 2000

23-Bove L, Picardo M, Maresca V, Jandolo B, Pace A.: A Pilot study

on the relationship between cisplatin neuropathy and Vitamin. E. J Exp

Clin Cancer Res 2001; 20 (2): 277-280.

24-Pace A.: Cure palliative in Neuro-Oncologia. Notiziario dei

Comitati Ghirotti. Luglio/Settembre 2001.

25-Pompili A, Caperle M, Pace A, Ramazzotti V, Raus L, Jandolo B,

Occhipinti El: Quality of life evaluation in patients operated upon for

cerebellar pilocytic astrocytoma. J Neurosurgery 96:229-234, 2002

26-Pace A, Maschio M: Terapia Medica nei Gliomi di Basso Grado.

Neurol Sci 2002 23:s7-s9.

27-Pace A et al: Un modello di assistenza continuativa per malati con

tumore cerebrale. Rivista Italiana di Cure Palliative, vol 4 n 2, 2002.

28-Santanelli F, Tenna S, Pace A, Scuderi N: .Free flap reconstruction

of the sole of the foot with or without sensory nerve coaptation. Plast

Reconstr Surg. 2002 Jun;109(7):2314-22

29-Pace et al: Neuroprotective Effect of Vitamin E Supplementation in

Patients Treated With Cisplatin Chemotherapy. J Clin Oncol. 2003 Mar

1;21(5):927-31. 2003.

30-Leonetti C, Biroccio A, Gabellini C, Scarsella M, Maresca V, Flori

E, Bove L, Pace A, Stoppacciaro A, Zupi G, Cognetti F, Picardo M:

Alpha-tocopherol protects against cisplatin-induced toxicity without

interfering with antitumor efficacy. Int J Cancer. 2003 Mar

20;104(2):243-50.

31-Galie E, Pietrangeli A, Maschio M, Pace A, Vidiri A, Carosi M,

Jandolo B.: Demyelinating disease in monoclonal gammopathy of

undetermined significance. J Exp Clin Cancer Res. 2003

Jun;22(2):337-9.

32-Pace A, Vidiri A, Galie E, Carosi M, Telera S, Cianciulli AM,

Canalini P, Giannarelli D, Jandolo B, Carapella CM. Temozolomide

chemotherapy for progressive low-grade glioma: clinical benefits and

radiological response. Ann Oncol. 2003 ;14(12):1722-6.

33-Pace A.:Complicanze midollari iatrogene. Neurol Sci 2003;24.

34-Fabi A, Vidiri A, Carapella C, Pace A, Occhipinti E, Caroli F, Mirri

A, Carlini P, Cognetti F: Bone metastasis from glioblastoma

multiforme without central nervous system relapse: a case report.

Anticancer Research 24 2004

35- Reni M, Mason W, Zaja F, Perry J, Franceschi E, Bernardi D,

Dell'Oro S, Stelitano C, Candela M, Abbadessa A, Pace A, Bordonaro

R, Latte G, Villa E, Ferreri AJ. Salvage chemotherapy with

temozolomide in primary CNS lymphomas: preliminary results of a

phase II trial.European Journal of Cancer 2004 Jul;40(11):1682-8

36-Pace A, Pompili A: Depression in Patients with High-grade Glioma:

Results of the Glioma Project. Neurosurgery. 56(4):E873, April 2005.

37-Pace, Bove L, Jandolo B:Vitamin E and cisplatin neurotoxicity.

Neurology. 2005 Aug 9;65(3):501-2 l

38-Pace A: Diagnosi e trattamento delle Meningiti Neoplastiche.

Medicina & terapia. Supplemento 2005. Edimes

39- A. Pace:Neuropatie da farmaci:criteri diagnostici e

neuroprotezione. 2005;3:103-105.

40-Fabi A,Salesi N,Di Cocco B, Vidiri A, Visca P, Pace A, Carapella

C, De Paula U, Mirri A, Cognetti F: Choroid plexus carcinoma in the

adult: is there a role for chemotherapy? J Exp Clin Cancer Res.

2005;24(3):493-6.

41- PompiliA, Pace A, Occhipinti E: Subtemporal Transtentorial

Approach. J Neurosurgery 104; 854-855, 2006

42 -Maschio M, Albani F,Baruzzi A,ZarablaA,Dinapoli L,Pace

A,Pompili A,Carapella CM,Occhipinti E,Jandolo B: Levetiracetam

therapy in patients with brain tumour and epilepsy.

J Neurooncol 2006: 80(1):97-100

43-Guido Cavaletti, Stefano Jann, Andrea Pace, Rosaria Plasmati,

Gabriele Siciliano, Chiara Briani, Dario Cocito, Luca Padua, Elisabetta

Ghiglione, Mariagrazia Manicone, Giuditta Giussani, in the context of

the Italian NETox Group: Multi-center assessment of the Total

Neuropathy Score for chemotherapy-induced peripheral neurotoxicity.

J Peripher Nerv Syst. 2006 Jun;11(2):135-41.

44-Pace A, Fabi A: Chemotherapy in neoplastic meningitis. Critical

rewiev in Oncology/Hematology. 2006

45-Vidiri A, Carapella CM, Pace A, Mirri A, Fabi A, Carosi MA,

Giannarelli D, Pompili A, Jandolo E,Occhipinti E, Di Giovanni S,

Crecco M: Early post-operative MRI: correlation with progression free

survival and overall survival time in malignant gliomas. Journal of

Experimental and Clinical Cancer Research 2006:25 (2);177-182

46-G Cavaletti, B Frigeni, F Lanzani, M Piatti, S Rota, C Briani, G

Zara, R Plasmati, F Pastorelli, A Caraceni, A Pace, M Manicone, A

Lissoni, N Colombo, G Bianchi, C Zanna for the Italian NETox

Group: The Total Neuropathy Score as a useful assessment tool for

grading the course of chemotherapy-induced peripheral neurotoxicity:

a comparison with the National Cancer Institute-Common Toxicity

Scale. J Peripher Nerv Syst. 2007 Sep;12(3):210-5

47-M Reni, F Zaja, W Mason, J Perry, E Mazza, M Spina, R

Bordonaro, F Ilariucci, M Faedi, G Corazzelli, P Manno, E Franceschi,

A Pace, M Candela, A Abbadessa, C Stelitano, G Latte and A J M

Ferreri: Temozolomide as salvage treatment in primary brain

lymphomas British Journal of Cancer (2007) 96, 864-867.

48-Andrea Pace, Cecilia Nisticò, Federica Cuppone, Emilio Bria,

Edvina Galiè,Giuliana Graziano, Guido Natoli, Isabella Sperduti,

Bruno Jandolo, Francesca Calabretta, Silverio Tomao, Edmondo

Terzoli:Peripheral Neurotoxicity of Weekly Paclitaxel Chemotherapy:

A Schedule or a Dose Issue? Clin Breast Cancer. 2007 Apr;7(7):550-4

49-Andrea Pace: Intrathecal chemotherapy treatment of neoplastic

meningitis from solid tumors using liposomal cytarabine: experience at

the Istituto Regina Elena di Roma. Tumori, 93 (3);9-12:2007

50-A Pace:Supportive care and end of life issues. Rivista Medica.

2007,vol 13 n 4

51-Pace A. Rehabilitation in brain tumor patients. J Exp Clin canc

Res,26,3,2007

52- Maschio M, Dinapoli L, Zarabla A, Pompili A, Carapella CM,

Pace A, Giannarelli D, Occhipinti E, Jandolo B: Outcome and

tolerability of topiramate in brain tumor associated epilepsy.. J

Neurooncol; 2007, 86(1): 61-70.

53- Nisticò C, Bria E, Cuppone F, Fornier M, Sperduti I, Carpino A,

Pace A, Cognetti F, Terzoli E.

Weekly epirubicin and paclitaxel with granulocyte colony-stimulating

factor support in previously untreated metastatic breast cancer patients:

a phase II study. Anticancer Drugs. 2007 Jul;18(6):687-92.

54-Andrea Pace, Cristiano Parisi, Maurizio Di Lelio. La Riabilitazione

palliativa. Un progetto per l’assistenza e la qualità della vita dei malati

neuro-oncologici. Riabilitazione Oggi. Anno XXIV, settembre 2007,

52-53

55- Fabi A, Mirri A, Felici A, Vidiri A, Pace A, Occhipinti E, Cognetti

F, Arcangeli G, Iandolo B, Carosi MA, Metro G, Carapella CM.Fixed

dose-rate gemcitabine as radiosensitizer for newly diagnosed

glioblastoma: a dose-finding study. J Neurooncol. 2008 Mar;87(1):79-

84 IF 3.115

56-Pompili A, Telera S, Pace A:Metastases to the cerebellum. Results

and prognostic factors in a consecutive series of 44 operated patients. J

Neurooncol. 2008 Jul;88(3):331-7 IF 3.115

57- Maschio M, Albani F, Jandolo B, Zarabla A, Contin M, Dinapoli

L, Fabi A, Pace A, Baruzzi A:

Temozolomide treatment does not affect topiramate and oxcarbazepine

plasma concentrations in chronically treated patients with brain tumor-

related epilepsy. J Neurooncol. 2008 Nov;90(2):217-21 IF 3.115

58-Andrea Pace, Cherubino Di Lorenzo, Lara Guariglia, B Jandolo,

Carmine M Carapella, Alfredo Pompili: End of life issues in brain

tumor patients. J Neurooncol. 2009 Jan;91(1):39-43 IF 3.115

59-Anna Maria Di Nallo, Antonello Vidiri, Simona Marzi, Alessandra

Mirri, Alessandra Fabi, Carmine Maria Carapella, Andrea Pace and

Marcello Crecco: Quantitative analysis of CT-perfusion parameters in

the evaluation of brain gliomas and metastases. Journal of

Experimental & Clinical Cancer Research 2009, 28:38 IF 3.07

60-Alessandra Fabi, Giulio Metro, Michelangelo Russillo, Antonello

Vidiri, Carmine M Carapella, Marta Maschio, Francesco Cognetti,

Bruno Jandolo, Maria A Mirri, Isabella Sperduti, Stefano Telera,

Mariantonia Carosi and Andrea Pace: Treatment of recurrent malignant

gliomas with fotemustine monotherapy: impact of dose and correlation

with MGMT promoter methylation BMC Cancer 2009, 9:101IF 3.33

61- Maschio M, Dinapoli L, Vidiri A, Pace A, Fabi A, Pompili A,

Carapella MC, Jandolo B.:The role side effects play in the choice of

antiepileptic therapy in brain tumor-related epilepsy: a comparative

study on traditional antiepileptic drugs versus oxcarbazepine J Exp

Clin Cancer Res. 2009 May 6;28:60. IF 3.07

62 - Dinapoli L, Maschio M, Jandolo B, Fabi A, Pace A, Sperati F,

Muti P.:Quality of life and seizure control in patients with brain tumor-

related epilepsy treated with levetiracetam monotherapy: preliminary

data of an open-label study. Neurol Sci. 2009 May 5. I.F. 1.22

63 - Cavaletti G, Cornblath DR, Postma TJ, Merkies IS, Argyriou A,

Boogerd W, Briani C, Bruna J, Faber CG, Grisold W, Heimans JJ,

Kalofonos H, Krarup-Hansen A, Koeppen S, Lauria G, Leandri M,

Mielke S, Nobile-Orazio E, Pace A, Padua L, Plasmati R, Psimaras D,

Ros T, Schenone A, Stragliotto G, Galimberti S, Valsecchi MG. CI-

PERINOMS Study Group: CI-PERINOMS: chemotherapy-induced

peripheral neuropathy outcome measures study. J Peripher Nerv Syst.

2009 Jun;14(2):69-71. IF 2.57

64-Pace A, Di Lorenzo C, Guariglia L, Zaratti M: Complicanze

neurologiche in oncologia. Clinical Management Issues 2010;4 (1)

49:56

65-Pace A, Giannarelli D, Galiè E, Savarese A, Carpano S, Della

Giulia M, Pozzi A, Silvani A, Gaviani P, Scaioli V, Jandolo B, Bove L,

Cognetti F. Vitamin E neuroprotection for cisplatin neuropathy: A

randomized, placebo-controlled trial. Neurology. 2010 Mar

2;74(9):762-6. IF 8.25

66- Metro G, Fabi A, Mirri MA, Vidiri A, Pace A, Carosi M, Russillo

M, Maschio M,

Giannarelli D, Pellegrini D, Pompili A, Cognetti F, Carapella CM.

Phase II study of fixed dose rate gemcitabine as radiosensitizer for

newly diagnosed glioblastoma multiforme. Cancer Chemother

Pharmacol. 2010 Jan;65(2):391-7. Epub 2009 Oct 22. IF 2.795

67-Alessandra Fabi, Giulio Metro, Antonello Vidiri, Gaetano Lanzetta,

Mariantonia Carosi, Stefano Telera, Marta Maschio, Michelangelo

Russillo , Isabella Sperduti, Carmine M. Carapella, Francesco Cognetti,

Andrea Pace. Low-dose fotemustine for treatment of recurrent

malignant glioma: a multicenter phase II study. J Neurooncol 2010 IF

3.115

68 -Pace A et al:Come ottimizzare le terapie orali in neuroncologia.

THERAPY PERSPECTIVES Anno XII, N. XX, maggio 2010

69-Pace A, Metro G, Fabi A: Supportive care in neurooncology.

Current Opinion in Oncology 2010 IF 4.027

70- Maschio M, Dinapoli L, Sperati F, Pace A, Fabi A, Vidiri A, Muti

P. Levetiracetam monotherapy in patients with brain tumor-related

epilepsy: seizure control, safety, and quality of life. J Neurooncol.

2011 Aug;104(1):205-14 IF 3.115

71-Fabi A, Felici A, Metro G, Mirri A, Bria E, Telera S, Moscetti L,

Russillo M,

Lanzetta G, Mansueto G, Pace A, Maschio M, Vidiri A, Sperduti I,

Cognetti F, Carapella CM. Brain metastases from solid tumors: disease

outcome according to type of treatment and therapeutic resources of

the treating center. J Exp Clin Cancer Res. 2011 Jan 18;30:10 IF 3.07

72-Vidiri A, Guerrisi A, Pinzi V, Fabi A, Mirri MA, Pompili A,

Caporale N, Pace A, Crecco M, Marzi S. Perfusion Computed

Tomography (PCT) adopting different perfusion metrics: Recurrence

of brain metastasis or radiation necrosis? Eur JRadiol. 2011 Mar 30. IF

2.645

73-Maschio M, Dinapoli L, Mingoia M, Sperati F, Pace A, Pompili A,

Carapella CM, Vidiri A, Muti P. Lacosamide as add-on in brain tumor-

related epilepsy: preliminary report on efficacy and tolerability. J

Neurol. 2011 Jun 16. IF 3.578

74- Pace A: Pain treatment as a human right. World Neurology 26;3,

2011

75-Pace A. Epilepsy, supportive care and cognitive rehabilitation.

Rivista Medica 2011; 17 (suppl 1), 50-59

76-Maschio M, Dinapoli L, Sperati F, Fabi A, Pace A, Vidiri A, Muti

P.Oxcarbazepine monotherapy in patients with brain tumor-related

epilepsy:open-label pilot study for assessing the efficacy, tolerability

and impact on quality of life. J Neurooncol. 2011 Aug 17. IF 3.115

77-Maschio M, Dinapoli L, Fabi A, Pace A, Vidiri A, Muti P. Eritema

multiforme durante radioterapia in 4 pazienti con epilessia secondaria

a neoplasia cerebrale in monoterapia con oxcarbazepina. Boll Lega

It Epil. 2011: 142;167-9

78-Michelangelo Bartolo, Chiara Zucchella, Andrea Pace, Gaetano

Lanzetta, Carmine Vecchione, Marcello Bartolo, Giovanni Grillea,

Mariano Serrao, Francesco Pierelli, Cristina Tassorelli, Giorgio

Sandrini: Early rehabilitation after surgery improves functional

outcome in brain tumors inpatients. J Neurooncol 2012

May;107(3):537-44 IF 3.115

79- The chemotherapy-induced peripheral neuropathy outcome

measure standardization (CI-PERINOMS) study: an answer to the

unsettled question of drug-related neuropathy assessment in cancer

patients. The CI-PERINOMS Study Group. EANO Magazine 2011; 2

(1), 37-39

80- Pace A, Di Lorenzo C, A Capon, V Villani, D Benincasa, Guariglia

L, M Salvati, C Brogna, V Mantini, Padovan A, Mastromattei, Pompili

A: Quality of care and rehospitalization rate in the last stage of disease

in malignant gliomas assisted at home: a cost effectiveness study J

Palliat Med. 2012 Feb;15(2):225- IF 1.891

81 -Antonello Vidiri, Andrea Pace, Alessandra Fabi, Marta Maschio,

Gaetano Marco Latagliata, Vincenzo Anelli, Francesca Piludu,

Carmine Maria Carapella, Giuseppe Giovinazzo and Simona Marzi:

Early perfusion changes in patients with recurrent high-grade brain

tumor treated with Bevacizumab: preliminary results by a quantitative

evaluation Journal of Experimental & Clinical Cancer Research 2012,

Apr 11;31(1):33-7 IF 3.07

82 Chiara Zucchella , Andrea Pace , Francesco Pierelli , Michelangelo

Bartolo. Riabilitazione cognitiva in pazienti neuro-oncologici: tre casi

clinici. Clinical Management Issues 2012; 6(2); 67-73

83 Cavaletti G, Cornblath DR, Merkies ISJ, Postma TJ, Rossi E,

Frigeni B, Alberti P, Bruna J, Velasco R, Argyriou AA, Kalofonos HP,

Psimaras D, Ricard D, Pace A, Galiè E., Briani C, Dalla Torre C

,Faber CG, Lalisang RI, Boogerd W, Brandsma D, Koeppen S, Hense

J, Storey D, Kerrigan S, Schenone A, Fabbri. S, Valsecchi MG and the

CI-PeriNomS Group (*)

The Chemotherapy-Induced Peripheral Neuropathy Outcome Measures

Standardization (CI-PeriNomS) study: from consensus to the first

validity and reliability findings. Annals of Oncology 2013 24(2):454-

62. IF 6.425

84 Pace A, Di Lorenzo C, Villani V, Guariglia L, Maschio M, Pompili

A, Carapella CM. Epilepsy at the end of life in malignant gliomas. J

Neuro-oncology. 2013 Jan;111(1):83-6. IF 3.115

85 Andrea Pace, Edvina Galiè, Tatiana Koudriavtseva.Neuroprotective

strategies in the prevention of chemotherapy-induced neuropathies. J of

Supportive Care in Cancer. Support Care Cancer. 2013 Jan;21(1):1-2

IF 2.649

86 Pace A, Villani V Extra-Cranial Metastases from Glioblastoma

Multiforme. EANO Magazine 2012

87 Andrea Pace, Veronica Villani, Chiara Zucchella, Marta Maschio

Quality of Life of Brain Tumour Patients EANO Magazine 2012

88 Michelangelo Bartolo, Chiara Zucchella, Andrea Pace, Alessandro

M De Nunzio, Mariano Serrao, Giorgio Sandrini and Francesco

Pierelli. Improving neuro-oncological patients care: basic and practical

concepts for nurse specialist in neuro-rehabilitation. Journal of

Experimental & Clinical Cancer Research 2012, 31:82 IF 3.07

89 Dinapoli, L., Maschio, M., Mingoia, M., Sperati, F., Fabi, A., Pace,

A., Petreri, G., Muti, P. Add-on lacosamide in brain tumor-related

epilepsy. Preliminary report: Efficacy and tolerability | Lacosamide

come antiepilettico in add-on in pazienti affetti da epilessia secondaria

a tumore cerebrale (2012) Bollettino - Lega Italiana contro l'Epilessia

(144) PP. 195 - 197

90 Maschio M, Dinapoli L, Sperati F, Pace A, Fabi A, Vidiri A,

Pompili A, Carapella CM. Effect of pregabalin add-on treatment on

seizure control, quality of life, and anxiety in patients with brain

tumour-related epilepsy: a pilot study. Epileptic Disord. 2012

14(4):388-97.

91 Graceffa D, Maiani E, Pace A, Solivetti FM, Elia F, De Mutiis C,

Bonifati C. Psoriatic Arthritis during Treatment with Bevacizumab for

Anaplastic Oligodendroglioma. Case Report Rheumatol.

2012;2012:208606. doi: 10.1155/2012/208606. Epub 2012 Nov 29

92 Chiara Zucchella, Michelangelo Bartolo, Cherubino Di Lorenzo,

Veronica Villani, Andrea Pace, Cognitive impairment in primary brain

tumors outpatients: a prospective cross-sectional survey. J Neuro

Oncology, 2013 112(3):455-60. IF 3.115

93 Telera S, Fabi A, Pace A, Vidiri A, Anelli V, Carapella CM,

Marucci L, Crispo F, Sperduti I, Pompili A. Radionecrosis induced by

stereotactic radiosurgery of brain metastases: results of surgery and

outcome of disease. J Neurooncol. 2013 Mar 25. IF 3.115

94 Binda D, Vanhoutte EK, Cavaletti G, Cornblath DR, Postma TJ,

Frigeni B, Alberti P, Bruna J, Velasco R, Argyriou AA, Kalofonos HP,

Psimaras D, Ricard D, Pace A, Galiè E, Briani C, Dalla Torre C,

Lalisang RI, Boogerd W, Brandsma D, Koeppen S, Hense J, Storey D,

Kerrigan S, Schenone A, Fabbri S, Rossi E, Valsecchi MG, Faber CG,

Merkies IS; CI-PeriNomS study group. Rasch-built Overall Disability

Scale for patients with chemotherapy-induced peripheral neuropathy

(CIPN-R-ODS). Eur J Cancer. 2013 May 10 IF 5.3

95 Salmaggi A, Simonetti G, Trevisan E, Beecher D, Carapella CM,

Dimeco F, Conti L, Pace A, Filippini G. Perioperative

thromboprophylaxis in patients with craniotomy for brain tumours: a

systematic review. J Neurooncol. 2013 113(2):293-303. IF 3.115

96 Zucchella C, Capone A, Codella V, De Nunzio AM, Vecchione C,

Sandrini G, Pace

A, Pierelli F, Bartolo M. Cognitive rehabilitation for early post-surgery

inpatients affected by primary brain tumor: a randomized, controlled

trial. J Neurooncol. 2013 May 16. IF 3.115

98 P. Alberti, E. Rossi, D. R. Cornblath, I. S. J. Merkies, T. J. Postma,

B. Frigeni, J. Bruna, R. Velasco, A. A. Argyriou, H. P. Kalofonos, D.

Psimaras, D. Ricard, A. Pace, E. Galiè, C. Briani, C. Dalla Torre, C. G.

Faber, R. I. Lalisang, W. Boogerd, D. Brandsma, S. Koeppen, J. Hense,

D. Storey1, S. Kerrigan, A. Schenone, S. Fabbri, M. G. Valsecchi, G.

Cavaletti and the CI-PeriNomS Group (**) Physician-assessed and

patient-reported outcome measures in chemotherapy-induced sensory

peripheral neurotoxicity: two sides of the same coin. Annals of

Oncology 2014 Jan;25(1):257-64 IF 6.425

99 Andrea Pace, Veronica Villani, Dario Benincasa, Antonella Di

Pasquale. Palliative and supportive care in neuro-oncology. Review in

Oncology 2013

100 Minniti G, Arcella A, Scaringi C, Lanzetta G, Di Stefano D,

Scarpino S, Pace A, Giangaspero F, Osti MF, Enrici RM.

Chemoradiation for anaplastic oligodendrogliomas: clinical outcomes

and prognostic value of molecular markers. J Neurooncol. 2014

Jan;116(2):275-82. IF 3.115

101 A Pace, V Villani, A Di Pasquale, D Benincasa, L Guariglia, S

Ieraci, S Focarelli, CM Carapella and A Pompili . Home care for brain

tumour patients. Neurooncology Practice 2013

102 Maschio, M., Dinapoli, L., Fabi, A., Pace, A., Giannarelli, D. The

importance of a cognitive rehabilitation program in patients with brain

tumor-related epilepsy and cognitive deficits | L'importanza di un

percorso di riabilitazione cognitiva nel paziente con epilessia tumorale

con deficit neurocognitivi (2013) Bollettino - Lega Italiana contro

l'Epilessia (145) PP. 55 - 58

103 Johan A.F. Koekkoek, Linda Dirven, Jaap C. Reijneveld, Tjeerd J.

Postma, Robin Grant, Andrea Pace, Stefan Oberndorfer, Jan J.

Heimans, Martin J.B. Taphoorn Epilepsy in the end of life phase of

brain tumor patients: a systematic review Neurooncology Practice 2014

104 Griffith KA, Dorsey SG, Renn CL, Zhu S, Johantgen ME,

Cornblath DR, Argyriou AA, Cavaletti G, Merkies IS, Alberti P,

Postma TJ, Rossi E, Frigeni B, Bruna J, Velasco R, Kalofonos HP,

Psimaras D, Ricard D, Pace A, Galie E, Briani C, Torre CD, Faber CG,

Lalisang RI, Boogerd W, Brandsma D, Koeppen S, Hense J, Storey DJ,

Kerrigan S, Schenone A, Fabbri S, Valsecchi MG; the CI-PeriNomS

Group. Correspondence between neurophysiological and clinical

measurements of chemotherapy-induced peripheral neuropathy:

secondary analysis of data from the

CI-PeriNoms study. J Peripher Nerv Syst. 2014 May 10

105 Minniti G, Scaringi C, Arcella A, Lanzetta G, Di Stefano D,

Scarpino S, Bozzao A, Pace A, Villani V, Salvati M, Esposito V,

Giangaspero F, Enrici RM. IDH1 mutation and MGMT methylation

status predict survival in patients with anaplastic astrocytoma treated

with temozolomide-based chemoradiotherapy. J Neurooncol. 2014 Apr

20. [Epub ahead of print

106 Maschio M, Sperati F, Dinapoli L, Vidiri A, Fabi A, Pace A,

Pompili A, Carapella CM, Cantelmi T. Weight of epilepsy in brain

tumor patients. J Neurooncol. 2014 Jun;118(2):385-93

107 V. Vaccaro,1 A. Fabi,1 A. Vidiri,2 D. Giannarelli,3 G. Metro,4 S.

Telera,5 S. Vari,1 F. Piludu,2 M. A. Carosi,6 V. Villani,7 F. Cognetti,1

A. Pompili,5 L. Marucci,8 C. M. Carapella,5 and A.Pace7 Activity and

Safety of Bevacizumab Plus Fotemustine for Recurrent Malignant

Gliomas BioMed Research International Volume 2014, Article ID

351252, 7 pages

108 Lombardi G, Della Puppa A, Di Stefano AL, Pace A, Rudà R,

Tabouret E, Zagonel V. Gliomas. Biomed Res Int. 2014;2014:470523.

Epub 2014 Aug 26.

109 Pompili A, Telera S, Villani V, Pace A. Home palliative care and

end of life issues in glioblastoma multiforme: results and comments

from a homogeneous cohort of patients. Neurosurg Focus. 2014

Dec;37(6):E5.

110 Minniti G, Scaringi C, Lanzetta G, Terrenato I, Esposito V,

Arcella A, Pace A, Giangaspero F, Bozzao A, Enrici RM. Standard

(60 Gy) or Short-Course (40 Gy) Irradiation Plus Concomitant and

Adjuvant Temozolomide for Elderly Patients With Glioblastoma: A

Propensity-Matched Analysis. Int J Radiat Oncol Biol Phys. 2015 Jan

1;91(1):109-15.

111 Chiaravalloti A, Fiorentini A, Villani V, Carapella C, Pace A, Di

Pietro B, Di Russo C, Palumbo B, Floris R, Schillaci O. Factors

affecting ¹⁸F FDOPA standardized uptake value in patients with

primary brain tumors after treatment. Nucl Med Biol. 2015

Apr;42(4):355-9.

112 Villani V, Casini B, Pace A, Prosperini L, Carapella CM, Vidiri A,

Fabi A, Carosi M. The Prognostic Value of Pyrosequencing-Detected

MGMT Promoter Hypermethylation in Newly Diagnosed Patients with

Glioblastoma. Dis Markers. 2015;2015:604719. doi:

10.1155/2015/604719. Epub 2015 Aug 11.

113 Piludu F, Marzi S, Pace A, Villani V, Fabi A, Carapella CM,

Terrenato I, Antenucci A, Vidiri A. Early biomarkers from dynamic

contrast-enhanced magnetic resonance imaging to predict the response

to antiangiogenic therapy in high-grade gliomas. Neuroradiology. 2015

Sep 12. [Epub ahead of print]

114 Villani V, Carapella CM, Chiaravalloti A, Terrenato I, Piludu F,

Vidiri A,Schillaci O, Floris R, Marzi S, Fabi A, Pace A. The Role of

PET [18F]FDOPA in Evaluating Low-grade Glioma. Anticancer Res.

2015 Sep;35(9):5117-22. PubMed PMID:

26254416.

115 Lombardi G, Pace A, Pasqualetti F, Rizzato S, Faedi M, Anghileri

E, Nicolotto E, Bazzoli E, Bellu L, Villani V, Fabi A, Ferrazza P,

Gurrieri L, Dall'Agata M, Eoli M, Della Puppa A, Pambuku A,

D'Avella D, Berti F, Rudà R, Zagonel V. Predictors of survival and

effect of short (40 Gy) or standard-course (60 Gy)irradiation plus

concomitant temozolomide in elderly patients with glioblastoma: a

multicenter retrospective study of AINO (Italian Association of Neuro-

Oncology). J Neurooncol. 2015 Nov;125(2):359-67

116 Walbert T, Pace A. End-of-life care in patients with primary

malignant braintumors: early is better. Neuro Oncol. 2016 18 (1), pp.

7-8.

117 Binda D, Cavaletti G, Cornblath DR, Merkies IS; CI-PeriNomS

study group.Rasch-Transformed Total Neuropathy Score clinical

version (RT-TNSc(©) ) in patients with chemotherapy-induced

peripheral neuropathy. J Peripher Nerv Syst. 2015 Sep;20(3):328-32.

doi: 10.1111/jns.12140.

118 Villani V, Zucchella C, Cristalli G, Galiè E, Bianco F, Giannarelli

D, Carpano S, Spriano G, Pace AVitamin E neuroprotection against

cisplatin ototoxicity: preliminary results from a randomised, placebo-

controlled trial. Head and Neck, 2016 Apr;38 Suppl 1:E2118-21

119 Pace A, Villani V, Parisi C, Di Felice S, Lamaro M, Falcicchio C,

Bonucci A,Pugliese P, di Napoli A, Di Lallo D. Rehabilitation

pathways in adult brain tumor patients in the first 12 months of disease.

A retrospective analysis of services utilization in 719 patients. Support

Care Cancer. 2016 Jul 15. [Epub ahead of

120 Andrea Pace, Dario Benincasa and Veronica Villani. Trigger

symptoms at the end of life in brain tumor patients. WFNO Magazine

2016

121 Cordone I, Masi S, Carosi M, Vidiri A, Marchesi F, Marino M,

Telera S, Pasquale A, Mengarelli A, Conti L, Pescarmona E, Pace A,

Carapella CM. Brain stereotactic biopsy flow cytometry for central

nervous system lymphoma characterization: advantages and pitfalls. J

Exp Clin Cancer Res. 2016 Aug 27;35(1):128. doi: 10.1186/s13046-

016-0404-1.

122 Bartolo M, Chiò A, Ferrari S, Tassorelli C, Tamburin S, Avenali

M, Azicnuda E, Calvo A, Caraceni AT, Defazio G, DE Icco R,

Formisano R, Franzoni S, Greco E, Jedrychowska I, Magrinelli F,

Manera U, Marchioni E, Mariotto S, Monaco S, Pace A, Saviola D,

Springhetti I, Tinazzi M, DE Tanti A; Italian Consensus Conference on

Pain in Neurorehabilitation (ICCPN). Assessing and treating pain in

movement disorders, amyotrophic lateral sclerosis, severe acquired

brain injury, disorders of consciousness, dementia, oncology and

neuroinfectivology Eur J Phys Rehabil Med. 2016 Aug 31. [Epub

ahead of print]

123 Veronica Villani, Roberta Merola, Antonello Vidiri, Alessandra

Fabi, Mariantonia Carosi, Diana Giannarelli, Laura Marucci,

Marta

Maschio MD, Carmine M Carapella,

Andrea Pace. Temozolomide low

dose chemotherapy in newly diagnosed low grade gliomas: activity,

safety and long term follow up Tumori Journal 2016

124 Galié E, Renna R, Plantone D, Pace A, Marino M, Jandolo B,

Koudriavtseva T. Paraneoplastic Morvan's syndrome following

surgical treatment of recurrent thymoma: A case report. Oncol Lett.

2016 Oct;12(4):2716-2719.

125 Castelnuovo G, Giusti EM, Manzoni GM, Saviola D, Gatti A,

Gabrielli S, Lacerenza M, Pietrabissa G, Cattivelli R, Spatola CA,

Corti S, Novelli M, Villa V, Cottini A, Lai C, Pagnini F, Castelli L,

Tavola M, Torta R, Arreghini M, Zanini L, Brunani A, Capodaglio P,

D'Aniello GE, Scarpina F, Brioschi A, Priano L, Mauro A, Riva G,

Repetto C, Regalia C, Molinari E, Notaro P, Paolucci S, Sandrini G,

Simpson SG, Wiederhold B, Tamburin S. Psychological Treatments

and

Psychotherapies in the Neurorehabilitation of Pain: Evidences and

Recommendations from the Italian Consensus Conference on Pain in

Neurorehabilitation. Front Psychol. 2016 Feb 19;7:115. doi:

10.3389/fpsyg.2016.00115. Review. PubMed PMID: 26924998;

PubMed Central PMCID: PMC4759289.

126 Castelnuovo G, Giusti EM, Manzoni GM, Saviola D, Gatti A,

Gabrielli S, Lacerenza M, Pietrabissa G, Cattivelli R, Spatola CA,

Corti S, Novelli M, Villa V, Cottini A, Lai C, Pagnini F, Castelli L,

Tavola M, Torta R, Arreghini M,Zanini L, Brunani A, Capodaglio P,

D'Aniello GE, Scarpina F, Brioschi A, Priano L, Mauro A, Riva G,

Repetto C, Regalia C, Molinari E, Notaro P, Paolucci S, Sandrini G,

Simpson SG, Wiederhold B, Tamburin S. Psychological

Considerations in the Assessment and Treatment of Pain in

Neurorehabilitation and Psychological Factors Predictive of

Therapeutic Response: Evidence and Recommendations from the

Italian Consensus Conference on Pain in Neurorehabilitation. Front

Psychol. 2016 Apr 19;7:468. doi: 10.3389/fpsyg.2016.00468. Review.

PubMed PMID: 27148104; PubMed Central PMCID: PMC4835496.

127 Porro CA, Sandrini G, Truini A, Tugnoli V, Alfonsi E, Berliocchi

L, Cacciatori C, LA Cesa S, Magrinelli F, Sacerdote P, Valeriani M,

Tamburin S. Diagnosing and assessing pain in neurorehabilitation:

from translational research to the clinical setting. Evidence and

recommendations from the Italian Consensus Conference on Pain in

Neurorehabilitation. Eur J Phys Rehabil Med. 2016 Oct;52(5):717-729.

PubMed PMID: 27579580.

128 Tamburin S, Lacerenza MR, Castelnuovo G, Agostini M, Paolucci

S, Bartolo M, Bonazza S, Federico A, Formaglio F, Giusti EM,

Manzoni GM, Mezzarobba S, Pietrabissa G, Polli A, Turolla A,

Sandrini G; Italian Consensus Conference on Pain in

Neurorehabilitation (ICCPN). Pharmacological and non-

pharmacological strategies in the integrated treatment of pain in

neurorehabilitation. Evidence and recommendations from the Italian

Consensus Conference on Pain in Neurorehabilitation. Eur J Phys

Rehabil Med. 2016 Oct;52(5):741-752. PubMed PMID:

27579583.

129 Sandrini G, Tamburin S, Paolucci S, Boldrini P, Saraceni VM,

Smania N; Italian Consensus Conference on Pain in

Neurorehabilitation (ICCPN).. Time for a Consensus Conference on

pain in neurorehabilitation. Eur J Phys Rehabil Med. 2016

Oct;52(5):714-716. PubMed PMID: 27406655.

130 Tamburin S, Paolucci S, Magrinelli F, Musicco M, Sandrini G.

The Italian Consensus Conference on Pain in Neurorehabilitation:

rationale and methodology. J Pain Res. 2016 May 30;9:311-8. doi:

10.2147/JPR.S84646. PubMed PMID: 27313474; PubMed Central

PMCID: PMC4892860

131 Iole Cordone, Serena Masi,

Valentina Summa, Mariantonia Carosi,

Antonello Vidiri, Alessandra Fabi,

Alessia Pasquale, Laura Conti,

Immacolata Rosito, Carmine Maria Carapella, Veronica Villani and

Andrea Pace Over-expression of Syndecan-1, MUC-1 and stem cell

markers in breast cancer neoplastic meningitis: a cerebrospinal

fluid flow cytometry study. Breast Cancer res. Breast Cancer Res.

2017 Apr 11;19(1):46. doi: 10.1186/s13058-017-0827-4.

132 Russo M, Villani V, Taga A, Genovese A, Terrenato I, Manzoni

GC, Servadei F, Torelli P, Pace A. Headache as a presenting symptom

of glioma: A cross-sectional study. Cephalalgia. 2017 Jan

1:333102417710020.

133 Andrea Pace, Linda Dirven, Johan AF Koekkoek, Heidrun Golla,

Jane Fleming, , Roberta Rudà, Christine Marosi, Emilie Le Rhun,

Robin Grant, Kathy Oliver, Ingela Oberg, Helen J Bulbeck, Alasdair G

Rooney, Roger Henriksson, H Roeline W Pasman, Stefan Oberndorfer,

Michael Weller, Martin JB Taphoorn, on behalf of the European

Association of Neuro-Oncology palliative care task force. EANO

guidelines for palliative care in adult glioma patients. Lancet Oncol.

2017 Jun;18(6):e330-e340

134 Kieffer JM, Postma TJ, van de Poll-Franse L, Mols F, Heimans JJ,

Cavaletti G, Aaronson NK; CI-PeriNomS Group. Evaluation of the

psychometric properties of the EORTC chemotherapy-induced

peripheral neuropathy questionnaire (QLQ-CIPN20). Qual Life Res.

2017 Jun 20. doi: 10.1007/s11136-017-1626-1. [Epub ahead of

print]PubMed PMID: 28634676. IF 2.99

136 Clausola di coscienza e cura nell’assistenza al fine vita

LUDOVICA DE PANFILIS1, DANIELA CATTANEO, LUISANNA

COLA, MADDALENA GASPARINI, CORINNA PORTERI,

DANIELA TARQUINI, ALESSANDRO TIEZZI, SIMONE

VERONESE, SILVIA ZULLO, EUGENIO PUCCI, PER IL GRUPPO

DI STUDIO IN BIOETICA E CURE PALLIATIVE DELLA

SOCIETÀ ITALIANA DI NEUROLOGIA*. Recenti Prog Med 2017;

108: 216-220

3/7/2017